Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BYMicroorganisms

Gut-to-Liver Escape of Viable Streptococcus salivarius Fuels Alcoholic Liver Disease via Fn14-Dependent NF-κB Signaling.

6 affiliations
  1. 1School of Public Health, Guangxi Medical University, Nanning 530021, China.
  2. 2Guangxi Key Laboratory of AIDS Prevention and Treatment, Guangxi Medical University, Nanning 530021, China.
  3. 3Life Sciences Institute, Guangxi Medical University, Nanning 530021, China.
  4. 4Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-Constructed by the Province and Ministry, Nanning 530021, China.
  5. 5Department of Gastroenterology, Minzu Hospital of Guangxi Zhuang Autonomous Region, Nanning 530001, China.
  6. 6Department of Geriatric Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.

Abstract

Gut microbial dysbiosis contributes to alcoholic liver disease (ALD), but the pathogenic bacteria and mechanisms remain unclear. We investigated the role of Streptococcus salivarius (S. salivarius) in ALD mice using a modified 12-week NIAAA chronic-plus-binge ethanol regimen with oral gavage. S. salivarius aggravated hepatic steatosis, inflammation, fibrosis, and serum ALT elevation, while impairing colonic mucus and tight-junction integrity. Viable bacteria translocated from the gut to the liver. Integrated hepatic metabolomics and transcriptomics revealed disturbances in bile acid, glycerophospholipid, and choline metabolism and upregulation of Tnfrsf12a, encoding Fn14. S. salivarius activated NF-κB signaling without altering TLR2 or TLR4 abundance. Fn14 silencing or NF-κB inhibition attenuated the inflammatory response in vitro. Thus, our findings suggest that S. salivarius may contribute to ALD progression by impairing the intestinal barrier, translocating to the liver, and activating Fn14-dependent NF-κB signaling. The gut-liver translocation pathway and Fn14/NF-κB axis may represent therapeutic targets for ALD.

Related

  1. Genistein Has Beneficial Effects Against Non-Alcoholic Fatty Liver Disease Through Activation of the SIRT1/PPAR-α/PGC-1α and Nrf2 Signaling Pathways.
    Fahimeh Zamani-Garmsiri, Golnaz Goodarzi, Sadra Samavarchi Tehrani +3
    InflammationPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
  2. Shenze shugan capsules alleviate alcoholic liver injury in association with modulation of the TGF-β/smad4 signaling pathway
    Lu Wang, Qianyu Gu, Jia Tinghe +7
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCCrossref
  3. Metabolites derived from cell signaling pathways modulate AMPK-dependent autophagic flux in disease-relevant cell models under cellular stress conditions
    Shifaa O. Alshammari
    Scientific ReportsPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  4. Association between the fasting blood glucose to high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease in Chinese adults: a secondary analysis
    Da Lin, Gengbin Lin, Zhe Liu
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Role of the Hepatorenal Index in the Detection of HbA1c-Defined Dysglycemia in Patients With Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study
    Geethu Divakar, Sarin Vidya, Afrah Fathima Karimbanakkal Edakkattu +1
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{zhao2026guttoliver,
  title = {{Gut-to-Liver Escape of Viable Streptococcus salivarius Fuels Alcoholic Liver Disease via Fn14-Dependent NF-κB Signaling.}},
  author = {Ranran Zhao and Xinqian Gao and Shuaiyi Liang and Jiegang Huang and Zuming Ruan and Zongmao Li and Guangkun Zhang and Ping Cui and Li Ye and Hui Chen},
  journal = {Microorganisms},
  year = {2026},
  month = oct,
  doi = {10.3390/microorganisms14102297},
  url = {https://europepmc.org/article/MED/42943537},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Gut-to-Liver Escape of Viable Streptococcus salivarius Fuels Alcoholic Liver Disease via Fn14-Dependent NF-κB Signaling.
AU  - Ranran Zhao
AU  - Xinqian Gao
AU  - Shuaiyi Liang
AU  - Jiegang Huang
AU  - Zuming Ruan
AU  - Zongmao Li
AU  - Guangkun Zhang
AU  - Ping Cui
AU  - Li Ye
AU  - Hui Chen
PY  - 2026
DA  - 2026/10/09
JO  - Microorganisms
DO  - 10.3390/microorganisms14102297
UR  - https://europepmc.org/article/MED/42943537
AB  - Gut microbial dysbiosis contributes to alcoholic liver disease (ALD), but the pathogenic bacteria and mechanisms remain unclear. We investigated the role of Streptococcus salivarius (S. salivarius) in ALD mice using a modified 12-week NIAAA chronic-plus-binge ethanol regimen with oral gavage. S. salivarius aggravated hepatic steatosis, inflammation, fibrosis, and serum ALT elevation, while impairing colonic mucus and tight-junction integrity. Viable bacteria translocated from the gut to the liver. Integrated hepatic metabolomics and transcriptomics revealed disturbances in bile acid, glycerophospholipid, and choline metabolism and upregulation of Tnfrsf12a, encoding Fn14. S. salivarius activated NF-κB signaling without altering TLR2 or TLR4 abundance. Fn14 silencing or NF-κB inhibition attenuated the inflammatory response in vitro. Thus, our findings suggest that S. salivarius may contribute to ALD progression by impairing the intestinal barrier, translocating to the liver, and activating Fn14-dependent NF-κB signaling. The gut-liver translocation pathway and Fn14/NF-κB axis may represent therapeutic targets for ALD.
SN  - 2076-2607
ER  -